Elevance Health stock holds after strong quarterly beat

Published on 09/07/2026 at 23:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elevance Health stock is supported by a quarterly beat, a $407.05 opening price and a $88.28 billion market cap as analysts keep a Moderate Buy view.

Modernes Krankenhaus-Campus mit Glasfassade und Patienten im Eingangsbereich — Elevance Health Krankenversicherungs-Campus US2855211023 zeigt modernen Gebäudeeingang mit weitläufiger Grünanlage unter blauem Himmel, Illustration mit AI erstellt.

Elevance Health stock (ISIN US2855211023) opened at USD 407.05 on September 7, 2026, with a market cap of USD 88.28 billion and a 52-week range of USD 274.84 to USD 436.24.MarketBeat The latest reported quarter, announced on July 15, 2026, brought adjusted EPS of USD 7.45 and revenue of USD 49.83 billion, both above consensus.

Quarterly beat still sets the tone

On July 15, 2026, Elevance reported adjusted EPS of USD 7.45 versus estimates of USD 6.21, a gap of USD 1.24 per share, while revenue came in at USD 49.83 billion against USD 48.88 billion expected.MarketBeat The same release showed a net margin of 2.47 percent and return on equity of 14.64 percent, which gives the stock a clear earnings anchor going into the next update.

Analysts stay constructive

Research desks still lean positive, with 15 Buy ratings and eight Holds and a consensus target price of USD 440.90.MarketBeat Against the USD 407.05 opening level on September 7, 2026, that target sits USD 33.85 above the latest quoted level, or about 8.3 percent higher.

For investors, the dividend also matters: Elevance declared USD 1.72 per share, equal to USD 6.88 annualized, with the payout dated for September 25, 2026 and an ex-dividend date of September 10, 2026.MarketBeat

CarelonRx remains central

CarelonRx is one of the company's main operating engines, and the latest figures show why margin discipline matters more than headline revenue alone. The combination of USD 49.83 billion in quarterly sales, 2.47 percent net margin and USD 7.45 adjusted EPS points to a business that is still producing sizable earnings power, but not a high-margin profile.

Stock level to watch

Elevance Health stock traded at USD 407.05 on September 7, 2026, with the 52-week high at USD 436.24 and the 52-week low at USD 274.84.MarketBeat The share sits below the yearly peak but well above the low, which leaves the next move tied to the durability of earnings and the dividend profile.